CL2023000315A1 - Composición farmacéutica de corticosteroide intraarticular para el control del dolor - Google Patents

Composición farmacéutica de corticosteroide intraarticular para el control del dolor

Info

Publication number
CL2023000315A1
CL2023000315A1 CL2023000315A CL2023000315A CL2023000315A1 CL 2023000315 A1 CL2023000315 A1 CL 2023000315A1 CL 2023000315 A CL2023000315 A CL 2023000315A CL 2023000315 A CL2023000315 A CL 2023000315A CL 2023000315 A1 CL2023000315 A1 CL 2023000315A1
Authority
CL
Chile
Prior art keywords
intra
pharmaceutical composition
articular corticosteroid
pain control
articular
Prior art date
Application number
CL2023000315A
Other languages
English (en)
Spanish (es)
Inventor
Shih Sheue-Fang
Oscar Brown Carl
Original Assignee
Tlc Biopharmaceuticals Inc
Taiwan Liposome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals Inc, Taiwan Liposome Co Ltd filed Critical Tlc Biopharmaceuticals Inc
Publication of CL2023000315A1 publication Critical patent/CL2023000315A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CL2023000315A 2020-08-05 2023-02-01 Composición farmacéutica de corticosteroide intraarticular para el control del dolor CL2023000315A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05

Publications (1)

Publication Number Publication Date
CL2023000315A1 true CL2023000315A1 (es) 2023-09-22

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2023000315A CL2023000315A1 (es) 2020-08-05 2023-02-01 Composición farmacéutica de corticosteroide intraarticular para el control del dolor

Country Status (14)

Country Link
US (1) US12514820B2 (enExample)
EP (1) EP4192426A1 (enExample)
JP (1) JP2023537474A (enExample)
KR (1) KR20230048066A (enExample)
CN (1) CN116348093A (enExample)
AU (1) AU2021320774A1 (enExample)
BR (1) BR112023001926A2 (enExample)
CA (1) CA3187955A1 (enExample)
CL (1) CL2023000315A1 (enExample)
IL (1) IL300354A (enExample)
MX (1) MX2023001410A (enExample)
TW (1) TW202220668A (enExample)
WO (1) WO2022031898A1 (enExample)
ZA (1) ZA202301377B (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
BR112015000174A2 (pt) * 2012-07-05 2017-06-27 Taiwan Liposome Co Ltd método para o tratamento da artrite
EP4389218A3 (en) * 2017-03-14 2024-10-16 Seikagaku Corporation Composition for treating joint disease and kit containing same
EP3820479B1 (en) * 2018-07-09 2026-03-11 Taiwan Liposome Co., Ltd. Methods to reduce complications of intra-articular steroid
IL281513B1 (en) 2018-09-16 2026-07-01 Tlc Biopharmaceuticals Inc Preparations for the treatment of joint pain

Also Published As

Publication number Publication date
BR112023001926A2 (pt) 2023-03-07
AU2021320774A1 (en) 2023-03-09
EP4192426A1 (en) 2023-06-14
MX2023001410A (es) 2023-03-06
US12514820B2 (en) 2026-01-06
ZA202301377B (en) 2026-05-27
CA3187955A1 (en) 2022-02-10
TW202220668A (zh) 2022-06-01
KR20230048066A (ko) 2023-04-10
CN116348093A (zh) 2023-06-27
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
IL300354A (en) 2023-04-01
WO2022031898A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
CL2019003542A1 (es) Métodos de tratamiento para la fibrosis quística.
MX2022005994A (es) Uso del inhibidor de fak en la preparacion de un farmaco para el tratamiento contra tumores con mutacion nras.
PE20242299A1 (es) Composiciones agonistas de gip/glp1
CR20210563A (es) Compuestos y métodos para el tratamiento de covid-19
MX2015017307A (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington.
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
EA200870469A1 (ru) Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение
AR132497A1 (es) Combinación de obicetrapib amorfo e inhibidor de sglt2
AR127247A1 (es) Inhibidores de cdk2 de ciclopentilpirazol
AR119033A1 (es) Métodos para tratar cánceres asociados con virus con inhibidores de la histona deacetilasa
MX2024009444A (es) Métodos de tratamiento para la fibrosis quística
PE20250835A1 (es) Composiciones y uso de la tirzepatida
EA202190544A1 (ru) Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний
JOP20240269A1 (ar) حلقات كبيرة من إندازول و استخدامها
MX2021007330A (es) Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia.
BR112022025920A2 (pt) Tratamento de artrite reumatoide
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
MX2025010198A (es) Formulaciones de dosis de una sola unidad de alta concentracion y métodos de uso de estas
CO2025006782A2 (es) Composición farmacéutica para la prevención o tratamiento contra úlcera péptica relacionada a fármacos, que comprende zastaprazán o una sal farmacéuticamente aceptable del mismo
CO2025007025A2 (es) Formulaciones orales compactables de ibutamoren
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
MX2023001410A (es) Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.
MX2023013514A (es) Metodos para tratar la cistitis intersticial/sindrome de dolor en la vejiga.
AR128566A1 (es) Combinaciones de fármacos y métodos para tratar el cáncer de ovario